May 1, 1999Current Opinion in Rheumatology
Signaling and effector pathways
Population
Rheumatoid synovium
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Gene therapy for RA synovium remains experimental; leaves open clinical translation pending controlled trials.
Structured PICO
P
Population
Rheumatoid synovium
I
Intervention
Gene transfer using adenovirus and retroviral constructs
This review highlights the potential of gene therapy to target signaling and effector pathways in the rheumatoid synovium for the treatment of rheumatoid arthritis.
Cite This Study
Müller‐Ladner et al. (1999) studied this question.